ArticleBreast cancer (Tokyo, Japan)2023

Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast cancer.

Takeshi Murata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.